The official press release went out around midnight AEST.
https://www.prnewswire.com/news-releases/cardiex-receives-fda-510k-clearance-for-a-world-first-vascular-biometric-monitor--the-conneqt-pulse-301807814.html
Some of the news outlets that have already run with it, such as "Mass Device" and "Gadgets & Wearables".
This is a key phrase from the press release :
"The FDA's clearance of the Pulse democratizes CardieX's market leading SphygmoCor technology by bringing deep vascular insights and clinically relevant heart health metrics to market at a price point that is now affordable to all."
SphygmoCor technology, for the first time in the companies history, is available to the masses.
And this is the step change for CardieX. We have become a mass market business, not a niche business selling to large institutions.
Revenue, and the MC, will now move towards reflecting that.
CardieX current MC : USD $35.5M
Hmmmm.
Add to My Watchlist
What is My Watchlist?
